Stockreport

ORIC Pharmaceuticals, Inc. (ORIC) Discusses Rinzimetostat Dose Optimization Data and Phase III Trial Design in Metastatic Prostate Cancer Transcript [Seeking Alpha]

Oric Pharmaceuticals, Inc.  (ORIC) 
PDF Company Participants Dominic Piscitelli - Chief Financial Officer Jacob Chacko - President, CEO & Director Lori Friedman - Chief Scientific Officer Pratik Multa [Read more]